Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
25-26 September, 2025
Not Confirmed
Not Confirmed
29 September-02 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
25-26 September, 2025
Industry Trade Show
Not Confirmed
29 September-02 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
17 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/17/3151771/0/en/Foundation-for-Sarcoidosis-Research-Reacts-to-the-Announcement-of-aTyr-Pharma-s-Phase-3-Clinical-Trial-Results.html
16 Sep 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/atyr-hits-record-low-lung-disease-drug-fails-late-stage-trial-2025-09-15/
05 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/05/3145473/0/en/aTyr-Pharma-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
07 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/07/3129587/0/en/aTyr-Pharma-Announces-Second-Quarter-2025-Results-and-Provides-Corporate-Update.html
22 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/22/3119360/0/en/aTyr-Pharma-Announces-Last-Patient-Visit-in-Phase-3-EFZO-FIT-Study-of-Efzofitimod-in-Patients-with-Pulmonary-Sarcoidosis.html
26 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/26/3105763/0/en/aTyr-Pharma-to-be-Added-to-the-Russell-2000-and-Russell-3000-Indexes.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE